© 2024 SEISMIC TX. ALL RIGHTS RESERVED.
Cambridge, Mass., March 27, 2023 – Seismic Therapeutic, Inc., a biotechnology company using machine learning for immunology drug development, announced today that Melanie Manning has joined the company as Chief People Officer. She is an experienced and versatile human resources (HR) leader with more than 20 years of experience supporting business plans and developing programs to fully engage talent in multiple industries, including at biopharmaceutical companies Novartis and Biogen.
“Melanie joins us at a key time as Seismic plans for our transition from a discovery stage to a preclinical and eventual clinical organization, and I’m thrilled to welcome her to the team,” said Jo Viney, PhD, Co-Founder, President and CEO of Seismic Therapeutic. “She has an outstanding track record of enacting progressive HR programs, as well as the experience to implement additional creative strategies by which Seismic can continue to attract, retain, and develop talent. Moreover, her insights will be invaluable in further strengthening our culture as we fulfill our vision to build an exceptional organization that creates next generation immunology drugs for patients.”
“I’m excited to join Seismic and build on the company’s amazing workplace culture, commitment to community engagement, and diversity, equity, inclusion, and belonging,” Manning said. “I am dedicated and honored to help achieve the company’s strategic goals by building relationships, fostering trust and helping employees to be their best authentic selves. I look forward to working collaboratively with every Seismonaut to continue to cultivate what makes Seismic a special place to work, promoting innovation and creativity to develop new immunology biologics medicines enabled by machine learning.”
Before joining Seismic, Manning held leadership positions at Enspira HR Consulting, where she served as Vice President, Human Capital, acting as primary contact for HR advisory client engagements. Prior to Enspira, she was Chief Human Resources Officer for non-profit organization Upstream USA. Previously, she served as Head of Human Resources for the Infectious Diseases division of Novartis Institutes for BioMedical Research (NIBR). Before her tenure at Novartis, Manning served as Associate Director, Human Resources at Biogen. Earlier in her career, she held several human resources positions for divisions of Fidelity Investments, which included HR business partner and Center of Excellence program office roles. She has a Masters degree in Human Relations and a BA from the University of Oklahoma and completed Intensive Studies in French Literature and Civilization at Université de Clermont-Ferrand, France.
About Seismic Therapeutic
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to treat adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub. For more information, please visit www.seismictx.com.
Media Contact
Kathryn Morris, The Yates Network
914-204-6412
kathryn@theyatesnetwork.com
This links to an external website.